Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer
Status:
Terminated
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
Patients are being asked to take place in this research study because they have advanced
prostate cancer that has gotten worse after other treatments. If they join this study they
will receive a new combination of drugs that are used to treat prostate cancer.